Tag: AstraZeneca US trial

76% rather than 79% against virus

The coronavirus vaccine developed by Oxford University and AstraZeneca was 76% effective at preventing symptomatic illness, the pharmaceutical company released updated information, citing a new analysis of up-to-date results for its major US trial. On Monday, the drugmaker, released an interim data from a 32,000-person trial conducted this winter in the US, Chile and Peru. […]